You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hedgehog inhibitor

Showing 26 - 50 of 7,424
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Basal Cell Carcinoma, Radiotherapy; Complications Trial (radiation, other, drug)

Not yet recruiting
  • Basal Cell Carcinoma
  • Radiotherapy; Complications
  • Radiotherapy
  • +2 more
  • (no location specified)
Sep 30, 2022

Recurrent Acute Myeloid Leukemia Trial in Duarte (Bosutinib Monohydrate, Decitabine, Enasidenib Mesylate)

Withdrawn
  • Recurrent Acute Myeloid Leukemia
  • Bosutinib Monohydrate
  • +6 more
  • Duarte, California
    City of Hope Meidcal Center
Jun 7, 2022

Neurofibromatosis Type 1, Plexiform Neurofibroma Trial in United States (Binimetinib)

Active, not recruiting
  • Neurofibromatosis Type 1
  • Plexiform Neurofibroma
  • Birmingham, Alabama
  • +21 more
Dec 4, 2021

Peripheral T Cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)

Recruiting
  • Peripheral T Cell Lymphoma
  • Linperlisib in combined with Chidamide
  • Beijing, Beijing/China, China
  • +1 more
Oct 9, 2023

Esophageal Cancer Trial in Dallas (Itraconazole)

Active, not recruiting
  • Esophageal Cancer
  • Dallas, Texas
    Dallas VA Medical Center
Nov 2, 2021

Cutaneous T-cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)

Recruiting
  • Cutaneous T-cell Lymphoma
  • Linperlisib in combined with Chidamide
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Sep 8, 2023

Cervical Cancer Trial in Amsterdam (Anti-PD-1 antibody balstilimab)

Not yet recruiting
  • Cervical Cancer
  • Anti-PD-1 antibody balstilimab
  • Amsterdam, Netherlands
    Amsterdam UMC
Oct 17, 2023

A Study of the Genetic Analysis of Brain Disorders

Completed
  • Holoprosencephaly
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Dec 10, 2021

    Hepatocellular Carcinoma (HCC) Trial in Taiwan (Chidamide, Regorafenib)

    Recruiting
    • Hepatocellular Carcinoma (HCC)
    • Kaohsiung, Taiwan
    • +4 more
    Mar 14, 2023

    Pancreatic Cancer Trial in Amsterdam (gemcitabine and nab paclitaxel)

    Completed
    • Pancreatic Cancer
    • gemcitabine and nab paclitaxel
    • Amsterdam, Netherlands
      Academic Medical Center
    Jan 7, 2020

    Chronic Kidney Disease Trial (Part A - Lorundrostat QD + Dapaglifozin QD, Part A - Lorundrostat QD, Part B - Lorundrostat QD

    Not yet recruiting
    • Chronic Kidney Disease
    • Part A - Lorundrostat QD + Dapaglifozin QD
    • +2 more
    • (no location specified)
    Nov 27, 2023

    HIV Trial in Las Vegas, Austin (VH4004280, Placebo)

    Not yet recruiting
    • HIV Infections
    • Las Vegas, Nevada
    • +1 more
    Aug 21, 2023

    Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer Trial (OP-1250, Fulvestrant, Anastrozole)

    Not yet recruiting
    • Breast Cancer
    • +4 more
    • (no location specified)
    Aug 31, 2023

    Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Boston (Zentalis, Gemzar)

    Not yet recruiting
    • Advanced Pancreatic Adenocarcinoma
    • +2 more
    • Boston, Massachusetts
    • +1 more
    Aug 23, 2023

    Differentiated Thyroid Cancer Trial in Pavia (Pembrolizumab)

    Not yet recruiting
    • Differentiated Thyroid Cancer
    • Pavia, Lombardia, Italy
      Istituti Clinici Scientifici Maugeri
    May 5, 2023

    Advanced Solid Tumors, Recurrent or Refractory Medulloblastoma, Locally Advanced or Metastatic Basal Cell Carcinoma Trial in

    Completed
    • Advanced Solid Tumors
    • +2 more
    • Los Angeles, California
    • +4 more
    Dec 16, 2020

    Blood Vessel Function in Postmenopausal Women With Breast Cancer

    Active, not recruiting
    • Breast Cancer
    • Rochester, Minnesota
      Mayo Clinic
    Jan 17, 2023

    Healthy Trial in Biberach (BI 1810631, Itraconazole)

    Recruiting
    • Healthy
    • Biberach, Germany
      Humanpharmakologisches Zentrum Biberach
    Apr 27, 2023

    Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma, Recurrent Adenoid Cystic Carcinoma Trial in Boston (CB-103,

    Not yet recruiting
    • Adenoid Cystic Carcinoma
    • +2 more
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Mar 14, 2023

    Acute Myeloid Leukemia (AML) Trial in Birmingham, San Francisco, New York (ZN-d5 ZN-c3, ZN-c3)

    Recruiting
    • Acute Myeloid Leukemia (AML)
    • Birmingham, Alabama
    • +2 more
    Jan 3, 2023

    Vonoprazan, Helicobacter Pylori Infection, Proton Pump Inhibitor Trial in Hangzhou (Tegoprazan, Esomeprazole)

    Active, not recruiting
    • Vonoprazan
    • +2 more
    • Hangzhou, Zhejiang, China
      Hangzhou first people's Hospital
    Dec 2, 2022

    Advanced Solid Tumor Cancers, Medulloblastoma, Basal Cell Carcinoma Trial in Hong Kong, Japan, Taiwan (LDE225)

    Completed
    • Advanced Solid Tumor Cancers
    • +2 more
    • Hong Kong, Hong Kong
    • +3 more
    Dec 16, 2020

    Breast Cancer Trial in Wuhan (Adebrelimab, dalpiciclib)

    Recruiting
    • Breast Cancer
    • Wuhan, Hubei, China
      Tongji Hospital Affiliated of Tongji Medical College Huazhong Un
    Nov 20, 2023

    Her-2 Negative Breast Cancer, HRR Gene Mutation Trial in Guangzhou (Camrelizumab, Fluzoparib, Nab-paclitaxel)

    Recruiting
    • Her-2 Negative Breast Cancer
    • HRR Gene Mutation
    • Guangzhou, Guangdong, China
      First Affiliated Hospital, Sun Yat-Sen University
    Mar 7, 2023

    Atypical Hemolytic Uremic Syndrome (aHUS) Trial in Worldwide (Ravulizumab)

    Active, not recruiting
    Has Results
    • Atypical Hemolytic Uremic Syndrome (aHUS)
    • Ravulizumab
    • Aurora, Colorado
    • +19 more
    Nov 16, 2022